3 completed, 1 active not recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
Follow bremelanotide: new trials by email Literature Review of bremelanotide trials Research Report on bremelanotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity bremelanotide, tirzepatide - Obesity | Phase 2 | Active not recruiting | Palatin Technologies, Inc | 108 | 2024-08-05 | 2025-03-06 |
| A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease Bremelanotide, RAAS inhibition therapy - Kidney Disease | Phase 2 | Completed | Palatin Technologies, Inc | 16 | 2022-12-26 | 2024-10-17 |
| Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder bremelanotide - Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder | Phase 2 | Completed | Palatin Technologies, Inc | 612 | 2011-06-01 | 2014-12-18 |
| Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) Bremelanotide - Sexual Arousal Disorder | Phase 2 | Completed | Palatin Technologies, Inc | 2006-02-01 | 2011-02-23 |
Sexual Dysfunctions, Psychological (2) · Kidney Diseases (1) · Obesity (1)
United States (4) · Canada (1)
Robert Jordan (2) · James Tumlin, MD (1) · Jeffrey Edelson, MD, FRCPC (1)